Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
oncology
Press Release
Nov 13, 2024
Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics
Read More
Press Release
Oct 3, 2024
Steady Growth for ONCare Alliance With the Addition of Two New Practices in Nebraska and Illinois
Opportunities for Collaboration Continue to Draw Independent Large and Small Practices From Across the Country
Read More
Press Release
Apr 30, 2024
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
The project is aimed at developing novel approaches to enhance tumor immunogenicity to broaden the population of patients who can benefit from cancer immunotherapy.
Read More
Press Release
Feb 29, 2024
Powerhouses QCCA and NCCA Merge to Create a Transformative New Entity in Independent Practice Oncology and Cancer Care: ONCare Alliance, LLC
After years of successful collaboration, the esteemed organizations National Cancer Care Alliance (NCCA) and Quality Cancer Care Alliance (QCCA) have merged, culminating in the birth of a transformative new entity, ONCare Alliance, LLC.
Read More
Press Release
Dec 19, 2023
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer immunotherapies.
Read More
Press Release
Dec 1, 2023
HanchorBio to Present at the ESMO Immuno-Oncology 2023 Annual Congress
Read More
Press Release
Nov 17, 2023
Radical Imaging Announces First Extension Available for FlexView
DeepLook Medical’s DL Precise™ application enables one-click measurement and segmentation for regions of interest in FlexView
Read More
Press Release
Oct 26, 2023
Comprehensive Hematology Oncology, LLC Becomes the 20th Practice to Join QCCA’s National CIN of Independent Cancer Care Practices
Quality Cancer Care Alliance’s Nationwide Network of Independent Community Oncology Practices Welcomes Comprehensive Hematology Oncology, LLC, With Eight Locations Serving St. Petersburg-Tampa Bay Communities
Read More
Press Release
Oct 3, 2023
A New Publication Highlights the Use of cResponse in the Assessment of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer
A recent publication in "Cancer Discovery" reviewed Germline BRCA-associated pancreatic ductal adenocarcinoma (glBRCA PDAC) spectrum of responses to platinum and PARPi therapy, exploring the genomic and clinical features that may lead to different responses, and investigates the mechanisms of resistance.
Read More
Press Release
Oct 3, 2023
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101
Read More
Press Release
Aug 28, 2023
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies
Read More
Press Release
Aug 8, 2023
CanariaBio Announces Enrollment Completion of Phase 2 Study of Oregovomab in Combination With Niraparib in the Treatment of Recurrent Ovarian Cancer
Read More
Press Release
Jul 31, 2023
The Assistance Fund Opens New Program for Biliary Tract Cancer
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Biliary Tract Cancer
Read More
Press Release
Jul 24, 2023
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA
Read More
Press Release
Apr 4, 2023
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
After successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore tumor immunogenicity enhancers.
Read More
Press Release
Mar 15, 2023
TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma
Read More
Press Release
Mar 14, 2023
Gibson Oncology Expands Its Board of Directors With Accomplished Leadership in Oncology Clinical Development and Corporate Strategy
Read More
Press Release
Feb 7, 2023
MetiStream and Carilion Clinic Partner to Identify High-Risk Patients for Colon Cancer Using AI and NLP
Read More
Press Release
Jan 26, 2023
Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications
Read More
Press Release
Jan 24, 2023
Interactome Bio Features GIS Tool and Presents at the NCI Meeting: Solving Critical Problems in Cancer Control Using Spatial Science
Interactome Bio featured at NCI Meeting on Solving Critical Problems in Cancer Control Using Spatial Science
Read More
Press Release
Jan 5, 2023
Health Care Consulting Leader Monument Analytics Will Change Its Name to Stage Analytics™
Stage Analytics commits to focused growth in Health Economics and Outcomes Research (HEOR), Legal Services, Innovation and Education, and Project Management Services
Read More
Press Release
Dec 1, 2022
UPDATE: Cornerstone Specialty Network Hosts a Successful Community Oncology Focused Data Review Meeting: October 2022
Read More
Press Release
Dec 1, 2022
Cornerstone Specialty Network Hosts a Successful Community Oncology Focused Data Review Meeting: October 2022
Read More
Press Release
Oct 18, 2022
TVAX Biomedical Announces Receipt of $2 Million FDA Orphan Products Grant for Glioblastoma Study
Read More
Press Release
Oct 7, 2022
BioNTech Establishes Asia-Pacific Clinical Scale mRNA Manufacturing & Regional Research Centre
German-based biotechnology company BioNTech will establish a clinical scale research mRNA manufacturing facility in Australia, following an in-principle letter of intent signed with the Victorian Government.
Read More
Press Release
Sep 21, 2022
Scailyte Closes Series A Funding With a CHF 6 Million Investment to Develop Strategic Partnerships in Immuno-Oncology
Read More
Press Release
Sep 8, 2022
GRYT Health to Host Fourth Annual Global Virtual Cancer Conference (GVCC) in November 2022
Free Virtual Event Offers Cancer Education for Everyone, Live Sessions on Four Days and On-Demand After
Read More
Press Release
Aug 30, 2022
WELLCORNER, LLC LAUNCHES NEW HEALTH & WELLNESS PRODUCT LINES FOR CANCER PATIENTS AT ITS NURSE SYMPOSIUM ON JUNE 15, 2022
Read More
Press Release
Jul 14, 2022
Independent Oncology Networks Join Forces to Evolve Cancer Care by Launching Exigent Research
A new venture from the National Cancer Care Alliance (NCCA) and Quality Cancer Care Alliance (QCCA)
Read More
Press Release
Jul 12, 2022
Nilogen and Scailyte Are Joining Forces to Find the 'Right' Treatment for Every Patient
Read More
Press Release
Jun 12, 2022
Molecular International Prognostic Scoring System Developed for Myelodysplastic Syndromes
Efficient, Accurate Risk Stratification Will Transform Patient Care
Read More
Press Release
Jun 2, 2022
CancerLife, a Digital Health Company, With the Validation Institute, Announces Results of Its Phase 3 Trial That Raised EQ-5 Quality of Life (QOL) Scores by 14.3%
CancerLife is the first digital health consumer app validated to raise QoL for cancer patients
Read More
Press Release
May 12, 2022
Genzada Pharmaceuticals Opens Phase 1B Metastatic Breast Cancer Trial
Read More
Press Release
Apr 26, 2022
Brenda M. Sandmaier, M.D., Named ASTCT 2022-2023 President
Read More
Press Release
Apr 19, 2022
Scailyte's 5th Anniversary Mini-Symposium - Machine Learning Meets Multi-Omics for Precision Medicine
Bringing industry and academia together to discuss the potential impact of single-cell analytics powered by machine learning for precision medicine.
Read More
Press Release
Apr 11, 2022
Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis
Read More
Press Release
Mar 30, 2022
New York Times Best-Selling Author Kate Bowler Gets Real With Cancer Patients
Wellness House presents No Cure for Being Human, a free online event, Thursday, April 14
Read More
Press Release
Mar 16, 2022
Hera BioLabs Announces Exclusive Global License With Charles River
Charles River will license Hera's SRG rat (OncoRat), the first highly immunocompromised rat model
Read More
Press Release
Mar 7, 2022
Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology's Solid Tumor Medical Advisory Board
Read More
Press Release
Feb 23, 2022
Scailyte Hosts Webinar About Supervised Learning of Disease-Associated Cell States and Dynamics
Webinar on the latest developments in the analysis of single-cell data, including from transcriptomic and imaging technologies.
Read More
Press Release
Feb 14, 2022
Vivacitas Oncology to Present at the 2022 BIO CEO & Investor Conference
Read More
Press Release
Jan 25, 2022
CytoImmune Therapeutics Announces Publication Demonstrating Platelet-Derived Growth Factor D Signaling Activates Natural Killer (NK) Cells and Enhances NK Cell Survival
A PNAS study demonstrates platelet-derived growth factor D (PDGF-D) binding to PDGF receptor-beta (PDGFRβ) activates NK cells to enhance interleukin (IL)-15-mediated NK cell survival. City of Hope research suggests that the selective introduction of PDGF signaling in NK cells by IL-15 should benefit NK cell expansion and persistence and/or enhance effector function in NK cell-based immunotherapies.
Read More
Press Release
Jan 18, 2022
Vivacitas Oncology to Present a Poster on AR-67 at the 3rd Annual Glioblastoma Drug Development Summit
Read More
Press Release
Jan 17, 2022
Dr. Erkut Borazanci, MD, Joins Vivacitas Oncology's Pancreatic Medical Advisory Board
Read More
Press Release
Jan 10, 2022
Scailyte Closes Financing Round and Onboards Top Biotech Leaders to Prepare for Growth in 2022
First closing of Series A round and onboarding of top biotech leaders to fuel growth in 2022
Read More
Press Release
Jan 5, 2022
Oncolyze Announces FDA Orphan Drug Designation for OM-301 for the Treatment of Acute Myeloid Leukemia
Read More
Press Release
Dec 21, 2021
illumiSonics Inc. Expands Its Executive Management With the Appointment of Jochen Schweizer as Chief Operating Officer
Read More
Press Release
Dec 21, 2021
illumiSonics Inc. Expands Its Executive Management With the Appointment of Jochen Schweizer as Chief Operating Officer
Read More
Press Release
Dec 21, 2021
illumiSonics Inc. Expands Its Executive Management With the Appointment of Jochen Schweizer as Chief Operating Officer
Read More
Press Release
Nov 30, 2021
Vivacitas Oncology Announces Additions to Leadership Team and Board
Read More
Press Release
Nov 22, 2021
Vivacitas Oncology, Inc. to Present on AR-67 at the Annual 5th Meridian Clinical Trials Conference
Read More
Press Release
Nov 18, 2021
Vivacitas Oncology, Inc. and Image Analysis Group to Present on AR-67 Clinical Response Evaluation at the Society for Neuro-Oncology Annual Conference
Read More
Press Release
Nov 3, 2021
Iowa-Based Mission Cancer + Blood Joins the Quality Cancer Care Alliance's National Network
The Iowa-based 22-Location Mission Cancer + Blood Joins QCCAN's Rapidly Growing Clinically Integrated National Network
Read More
Press Release
Oct 25, 2021
OncDoc - the Easiest Way to Communicate With a Cancer & Blood Physician
Read More
Press Release
Sep 24, 2021
DoseOptics Receives 2nd FDA 510(k) Clearance for Multicamera High-Sensitivity BeamSite™ System
The world's first radiation dose imaging system now provides always-on, full patient coverage for clinical radiotherapy
Read More
Press Release
Sep 22, 2021
TTUHSC El Paso's Life-Saving Cancer Prevention Programs Receive $5 Million in CPRIT Funding
Read More
Press Release
Sep 7, 2021
The Quality Cancer Care Alliance Adds Cancer Center of Middle Georgia (CCMG) to Its National Network
CCMG's 6-Provider Team located in Dublin, Georgia, Joins QCCA's Nationally Clinically Integrated Network
Read More
Press Release
Aug 23, 2021
Privo Technologies, Inc. Awarded $3M NIDCR NIH Commercialization Readiness Pilot Grant
Read More
Press Release
Aug 19, 2021
Privo Technologies Named Winner of AIM-HI Accelerator Fund's Inaugural Women's Venture Competition
Read More
Press Release
Jul 6, 2021
TRIBVN Healthcare and CYPATH Announce a Multi-Year Partnership Agreement to Digitalize the CYPATH Pathology Group
CYPATH on Track to Lead the Way in Building the Future of Pathology
Read More
First
Prev
1
2
3
Next
Last